JP2024533273A5 - - Google Patents

Info

Publication number
JP2024533273A5
JP2024533273A5 JP2024514660A JP2024514660A JP2024533273A5 JP 2024533273 A5 JP2024533273 A5 JP 2024533273A5 JP 2024514660 A JP2024514660 A JP 2024514660A JP 2024514660 A JP2024514660 A JP 2024514660A JP 2024533273 A5 JP2024533273 A5 JP 2024533273A5
Authority
JP
Japan
Prior art keywords
seq
xaa
structurally stabilized
item
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024514660A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076114 external-priority patent/WO2023039474A1/en
Publication of JP2024533273A publication Critical patent/JP2024533273A/ja
Publication of JP2024533273A5 publication Critical patent/JP2024533273A5/ja
Pending legal-status Critical Current

Links

JP2024514660A 2021-09-08 2022-09-08 抗ウイルス性の構造的にステープル化されたSARS-CoV-2ペプチド-コレステロールコンジュゲートおよびその使用 Pending JP2024533273A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163241722P 2021-09-08 2021-09-08
US63/241,722 2021-09-08
PCT/US2022/076114 WO2023039474A1 (en) 2021-09-08 2022-09-08 Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof

Publications (2)

Publication Number Publication Date
JP2024533273A JP2024533273A (ja) 2024-09-12
JP2024533273A5 true JP2024533273A5 (cg-RX-API-DMAC10.html) 2025-09-16

Family

ID=83594405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024514660A Pending JP2024533273A (ja) 2021-09-08 2022-09-08 抗ウイルス性の構造的にステープル化されたSARS-CoV-2ペプチド-コレステロールコンジュゲートおよびその使用

Country Status (10)

Country Link
US (1) US20250084128A1 (cg-RX-API-DMAC10.html)
EP (1) EP4399220A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024533273A (cg-RX-API-DMAC10.html)
KR (1) KR20240052851A (cg-RX-API-DMAC10.html)
CN (1) CN118401542A (cg-RX-API-DMAC10.html)
AU (1) AU2022341116A1 (cg-RX-API-DMAC10.html)
CA (1) CA3231587A1 (cg-RX-API-DMAC10.html)
IL (1) IL311151A (cg-RX-API-DMAC10.html)
MX (1) MX2024002824A (cg-RX-API-DMAC10.html)
WO (1) WO2023039474A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120958134A (zh) * 2023-04-12 2025-11-14 西湖大学 用于抑制冠状病毒的融合脂肽
WO2025147479A1 (en) * 2024-01-04 2025-07-10 Merck Sharp & Dohme Llc Viral fusion inhibitors
WO2025235945A1 (en) * 2024-05-10 2025-11-13 Red Queen Therapeutics, Inc. Methods of treating viral infections using a fusion inhibitor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
ES2211033T3 (es) 1998-01-07 2004-07-01 Debio Recherche Pharmaceutique S.A. Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
US6348558B1 (en) 1999-12-10 2002-02-19 Shearwater Corporation Hydrolytically degradable polymers and hydrogels made therefrom
BR0001870B1 (pt) 2000-05-29 2014-02-25 Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
CN1223605C (zh) * 2003-05-16 2005-10-19 中国科学院微生物研究所 抑制sars冠状病毒的多肽药物及其衍生物和其应用
EP1680443B9 (en) 2003-11-05 2014-09-03 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
EP2208061B1 (en) 2007-09-26 2017-11-08 Dana Farber Cancer Institute Methods and compositions for modulating bcl-2 family polypeptides
WO2010060112A1 (en) 2008-11-24 2010-05-27 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with improved properties
EP3549951A3 (en) 2008-12-09 2019-11-20 Dana Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
EP3698811A1 (en) 2009-06-18 2020-08-26 Dana Farber Cancer Institute, Inc. Structured viral peptide compositions and methods of use
CA3010713A1 (en) * 2016-01-07 2017-07-13 Navigen, Inc. D-peptide inhibitors of hiv entry and methods of use
US20190048038A1 (en) 2016-02-23 2019-02-14 Dana-Farber Cancer Institute, Inc. Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting
EP4267166A4 (en) * 2020-12-22 2024-11-27 The University of Chicago Blockade of sars-cov-2 infection using hydrocarbon stapled peptides

Similar Documents

Publication Publication Date Title
JP6084207B2 (ja) 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのpsd−95の高親和性二量体阻害剤
JP5686825B2 (ja) メタスチン誘導体およびその用途
CN1126441A (zh) 使用聚合物放大维生素b12吸收系统
CN1200127A (zh) 新的阿片样肽
US20120010154A1 (en) Cytotoxic Conjugates Having Neuropeptide Y Receptor Binding Compound
JP2010189398A (ja) Pacapのペプチド類似体
IL240686A (en) Preparations containing cyclic peptides containing adjacent arginine residues
JPH04506664A (ja) 治療用ペプチド
TW202140513A (zh) 人類運鐵蛋白受體結合肽
JP3178835B2 (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
CN108395471B (zh) 抑制MERS-CoV感染的多肽
JPH05504558A (ja) 合成カルシトニンペプチド
US6897289B1 (en) Peptide synthesis procedure in solid phase
JPWO1992004374A1 (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
US5387671A (en) Hexa- and heptapeptide anaphylatoxin-receptor ligands
US5223485A (en) Anaphylatoxin-receptor ligands
CN1204341A (zh) 含d-2-烷基色氨酸、能促进生长激素释放的寡肽化合物
US5079231A (en) Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them
JP6952320B2 (ja) 新規nk3受容体アゴニスト
JPH0676437B2 (ja) Grf類似体
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
JPH10501003A (ja) 免疫調節作用を有する新規ペプチド
CN109153712B (zh) Peg化生物活性肽及其用途
CN1030255C (zh) 环形生长激素释放因子(grf)类似物的制备方法
JPS60237098A (ja) アルギニンバソプレツシン拮抗薬の新規誘導体類